ID: ALA3277934

Max Phase: Preclinical

Molecular Formula: C28H27ClN4O2

Molecular Weight: 450.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.N=C(N)c1ccc(OCc2cccc(-c3cccc(COc4ccc(C(=N)N)cc4)c3)c2)cc1

Standard InChI:  InChI=1S/C28H26N4O2.ClH/c29-27(30)21-7-11-25(12-8-21)33-17-19-3-1-5-23(15-19)24-6-2-4-20(16-24)18-34-26-13-9-22(10-14-26)28(31)32;/h1-16H,17-18H2,(H3,29,30)(H3,31,32);1H

Standard InChI Key:  FFKCGSXLPKKZJA-UHFFFAOYSA-N

Associated Targets(Human)

Thrombin 11687 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma 7708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Thrombin 1630 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glandular kallikrein 81 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 450.54Molecular Weight (Monoisotopic): 450.2056AlogP: 5.08#Rotatable Bonds: 9
Polar Surface Area: 118.20Molecular Species: BASEHBA: 4HBD: 4
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 12.12CX LogP: 4.60CX LogD: -0.23
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.21Np Likeness Score: -0.22

References

1. Geratz JD, Cheng MC, Tidwell RR..  (1976)  Novel bis(benzamidino) compounds with an aromatic central link. Inhibitors of thrombin, pancreatic kallikrein, trypsin, and complement.,  19  (5): [PMID:1271404] [10.1021/jm00227a011]

Source